- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
PAPER OF THE WEEK: When Patients With Kidney Failure Still Don't Take Medication
The article identifies issues such as poor socioeconomic background and lack of family and social support as factors in poor medication adherence, which today are recognized as social determinants of health
Welcome to Paper of the Week, which looks back at research and commentary from the past 25 years in The American Journal of Managed Care®, and why they matter today.
This week’s paper, “Medication Noncompliance in Patients With Chronic Disease: Issues in Dialysis and Renal Transplantation,” examines the problems with patients who must undergo a kidney transplant but still don’t stick with basic medication regimens for conditions like hypertension, which add to their medical challenges.
The article identifies issues such as poor socioeconomic background and lack of family and social support as factors in poor medication adherence, which today are recognized as social determinants of health.
This week, CMS offered a proposal for helping patients with end-stage renal disease enroll in Medicare Advantage, which complement payment models for renal treatment called Kidney Care First. Overall, the current initiatives in CMS are designed to make nephrologists, dialysis centers, and others involved in renal care more accountable for patients’ overall health.
For the Paper of the Week, visit ajmc.com.
For more about Kidney Care First, see ajmc.com.
Integrated CKD Care Model Cuts ED Visits by 30%, Boosts Specialized Treatment
April 21st 2025An analysis of an interdisciplinary care model for managing chronic kidney disease (CKD) shows hospital admissions dropped by 26% and emergency department (ED) visits decreased by 30% after clinic initiation.
Read More
National Data Show Rising Risk, Cost of CKD in Patients With Acute Myocardial Infarction
April 10th 2025A series of new studies from the National Kidney Foundation Spring Clinical Meeting exhibit the association between impaired kidney function and prolonged hospital stays, higher charges, and greater resource utilization.
Read More
Meta-Analysis Finds SGLT2 Inhibitors Boost Hemoglobin, Hematocrit in CKD
April 8th 2025The analysis supports the integration of sodium-glucose cotransporter 2 (SGLT2) inhibitors into treatment paradigms for patients with chronic kidney disease (CKD) not only for their established benefits but also for addressing anemia.
Read More
